Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Amyris Inc    AMRS

Delayed Quote. Delayed  - 07/29 10:00:00 pm
0.35 USD   -3.61%
07/19 AMYRIS : American Refining Group Invests in Novvi to Accelerate Comm..
07/19 American Refining Group Invests in Novvi to Accelerate Amyris Com..
07/18 Amyris to Announce Second Quarter Financial Results on Thursday, ..
News SummaryMost relevantAll newsSector news 

AMYRIS : Introduces EvoShieldTM Line of Industrial Lubricants

share with twitter share with LinkedIn share with facebook
share via e-mail
08/25/2011 | 02:10pm CEST

Amyris, Inc. (NASDAQ:AMRS), a leading renewable chemicals and fuels company, today unveiled EvoShieldTM, its new product line of industrial lubricants. The announcement was made during a speech delivered by Amyris CEO John Melo at the Infineon Raceway of Sonoma's inaugural Accelerating Sustainable Performance Summit.

EvoShield lubricants are a family of renewably-sourced solutions designed to satisfy the most advanced lubrication challenges without compromising quality or performance. EvoShield lubricants will be formulated from NovaSpecTM renewably-sourced synthetic base oils, derived from Amyris's Biofene®and produced by Novvi, Amyris's joint venture with Brazil's Cosan.

"Novvi's high-performance base oils, combined with advanced additive systems, will enable Amyris EvoShield products to perform in a range of applications under extreme conditions of temperature, moisture, dirt and wear, while improving upon key environmental metrics including renewability, toxicity and biodegradability when compared with petroleum-sourced lubricants," said John Melo, CEO of Amyris. "We are on track to begin production this year and to redefine performance for the lubricants industry."

These lubricants will provide ideal protection for equipment across a broad range of industrial applications, including hydraulic, compressor, turbine and gear oils, as well as specific formulations for marine and food-grade requirements.

"The Infineon Summit provides the ideal environment and platform to announce our new line of renewably-sourced, high-performance industrial lubricants," said Jim Richardson, president of lubricants and fuels for Amyris. "Motorsports require the highest-performing products to deliver under challenging and extreme conditions. These performance expectations are consistent with the needs of our industrial customers in a variety of different applications and we're excited to introduce EvoShield's capabilities at an event that emphasizes sustainability and highlights our environmental improvements over petroleum-based lubricants."

As the Official Renewable Fuels Provider of the Raceway, Amyris also showcased the performance of its renewable diesel during the summit by powering a 2011 Audi Q7 TDI around the track. This demonstration marked the first on-road operation of a vehicle fueled by 100 percent neat Amyris renewable diesel.

Amyris is scaling its Biofene production in Brazil, Europe and the United States through five production arrangements, including manufacturing agreements with Antibióticos S.A., Biomin do Brasil Nutri?ão Animal Ltda., Paraíso Bioenergia S.A., Tate & Lyle and a joint venture with Usina São Martinho S.A., one of the largest sugar and ethanol producers in Brazil. Amyris has also established finishing capabilities with Glycotech, Inc. in North Carolina.

About Amyris, Inc.

Amyris is an integrated renewable products company focused on providing sustainable alternatives to a broad range of petroleum-sourced products. Amyris uses its industrial synthetic biology platform to convert plant sugars into a variety of hydrocarbon molecules - flexible building blocks that can be used in a wide range of products. Amyris is commercializing these products both as No Compromise® renewable ingredients in cosmetics, flavors and fragrances, polymers, lubricants and consumer products, and also as No Compromise renewable diesel and jet fuel. Amyris Brasil Ltda., a subsidiary of Amyris, oversees the establishment and expansion of Amyris's production in Brazil. Amyris also has fuel distribution capabilities in the United States through its subsidiary, Amyris Fuels, LLC. More information about Amyris is available at www.amyris.com.

Forward-Looking Statements

This release contains forward-looking statements, and any statements other than statements of historical facts could be deemed to be forward-looking statements. These forward-looking statements include, among other things, statements regarding future events (such as statements regarding the performance attributes and environmental benefits of our lubricants products and the timing of their production) that involve risks and uncertainties. These statements are based on management's current expectations and actual results and future events may differ materially due to risks and uncertainties, including those associated with any delays or failures in development, production or commercialization of products, our reliance on third parties to achieve our goals, and other risks detailed in the "Risk Factors" section of Amyris's annual report on Form 10-K filed on March 14, 2011 and quarterly reports on Form 10-Q filed on May 11, 2011 and August 11, 2011. Amyris disclaims any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.

Amyris, Biofene, EvoShield, and No Compromise are trademarks or registered trademarks of Amyris, Inc.

Schwartz Communications
Merrill Freund or Alison Mickey, 415-512-0770 (Press)

© Business Wire 2011
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on AMYRIS INC
07/19 AMYRIS : American Refining Group Invests in Novvi to Accelerate Commercializatio..
07/19 American Refining Group Invests in Novvi to Accelerate Amyris Commercializati..
07/18 Amyris to Announce Second Quarter Financial Results on Thursday, August 4, 20..
07/01 AMYRIS : Ginkgo Bioworks and Amyris Partner to Accelerate Commercialization of B..
06/30 AMYRIS : Ginkgo Bioworks and Amyris Partner to Accelerate Commercialization of B..
06/29 AMYRIS, INC. : Entry into a Material Definitive Agreement, Creation of a Direct ..
06/29 AMYRIS, INC. : Entry into a Material Definitive Agreement (form 8-K)
06/29 Ginkgo Bioworks and Amyris Partner to Accelerate Commercialization of Bio-Bas..
06/28 Amyris Announces Long term, Multi-Million-Dollar Collaboration in Cosmetic Ac..
06/20 AMYRIS, INC. : Notice of Delisting or Failure to Satisfy a Continued Listing Rul..
More news
Sector news : Industrial Biotechnology Chemicals
07/28DJNew Henkel CEO Makes Amends -- WSJ
07/26DJHenkel's New CEO Faces Task of Maintaining Pace Set by Predecessor
07/21 Unilever sharpens P&G rivalry by buying Dollar Shave Club
07/14DJJohnson Matthey Appoints Anna Manz Group Finance Director
07/06 HENKEL KGAA : French competition body fines Henkel, others over exclusive import..
More sector news : Industrial Biotechnology Chemicals
News from SeekingAlpha
06/17 INSIDERINSIGHTS.COM DAILY ROUND UP 6 : TICC Capital, Shake Shack, New Relic, Pdv..
06/13 Cathay Pacific starts two-year program to use Amaris renewable jet fuel
05/10 Amyris' (AMRS) CEO John Melo on Q1 2016 Results - Earnings Call Transcript
05/10 Amyris misses by $0.04, misses on revenue
05/09 Notable earnings after Tuesday?s close
Financials ($)
Sales 2016 94,3 M
EBIT 2016 -6,46 M
Net income 2016 -69,9 M
Debt 2016 -
Yield 2016 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales 2016 0,78x
Capi. / Sales 2017 0,60x
Capitalization 73,9 M
More Financials
Duration : Period :
Amyris Inc Technical Analysis Chart | AMRS | US03236M1018 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Mean consensus OUTPERFORM
Number of Analysts 2
Average target price 2,63 $
Spread / Average Target 650%
Consensus details
EPS Revisions
More Estimates Revisions
John G. Melo President, Chief Executive Officer & Director
Geoffrey M. Duyk Chairman
Raffi Asadorian Chief Financial Officer
Joel Cherry President-Research & Development
Louis John Doerr Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
AMYRIS INC-78.40%74
HENKEL AG & CO KGAA7.95%50 370
SASOL LIMITED-11.47%17 309
SIKA AG20.11%10 081
SYMRISE AG4.35%9 145
More Results